CONSISTENCY IN TIME TO RESPONSE WITH UPADACITINIB AS MONOTHERAPY OR COMBINATION THERAPY AND ACROSS PATIENT POPULATIONS WITH RHEUMATOID ARTHRITIS

Rubbert-Roth, A; Combe, B; Szekanecz, Z; Hall, S; Haraoui, B; Attar, S; Ekwall, AKH; Song, Y; Shaw, T; Nagy, O; Xavier, R

ANNALS OF THE RHEUMATIC DISEASES, 2022; 81 (): 613